KLOW 50/10/10/10mg – 10 Vial Box

$189.00

Availability: In Stock

Buy KLOW 50/10/10/10 mg peptide blend (one 10-vial box). GHK-Cu (50 mg), TB-500 (10 mg), BPC-157 (10 mg), and KPV (10 mg). All orders are shipped wholesale in unbranded packaging. Worldwide 7 – 14 day shipping to the USA, UK, AUS & NZ.

Category:

Description

KLOW is a multi-compound peptide blend consisting of GHK-Cu (50 mg), TB-500 (10 mg), BPC-157 (10 mg), and KPV (10 mg), formulated for research examining overlapping tissue remodeling and cellular signaling pathways.

  1. GHK-Cu is a copper-binding tripeptide investigated for its interactions with extracellular matrix remodeling, inflammatory cytokine expression, angiogenic signaling, and collagen synthesis regulation.
  2. TB-500 (TB-4) is a synthetic Thymosin Beta-4 analogue studied for its interactions with actin sequestration, fibroblast migration, and extracellular matrix reorganization across muscle, tendon, and ligament tissue models.
  3. KPV is a tripeptide derived from alpha-MSH investigated for its interactions with melanocortin receptor signaling, inflammatory cytokine modulation, and dermal cellular pathway activity.
  4. BPC-157 is a naturally occurring peptide studied for its observed effects on fibroblast proliferation, gastrointestinal epithelial integrity, tendon extracellular matrix remodeling, and inflammatory marker modulation.

These compounds are investigated in combination for their complementary mechanistic profiles across overlapping extracellular matrix, angiogenic, and inflammatory signaling pathways.

For Research Use Only. Not for Human Consumption.

Minimum order quantity: one box (10 vials x 80 mg, 800 mg of peptides in total).

Note: Product images show branded labels for illustration purposes only. All peptides are shipped in wholesale, unbranded packaging. You can see an actual example photo of the peptide vials and container above.

Reviews

There are no reviews yet.

Be the first to review “KLOW 50/10/10/10mg – 10 Vial Box”

Your email address will not be published. Required fields are marked *